TG Therapeutics, Inc. revenue
TG Therapeutics, Inc.'s revenue was $616m in fiscal 2025, up 87.3% on the year before. Since fiscal 2016 ($152,000) it has grown at a compound 151.7% a year. Over the last twelve months it was $800m.
Revenue history
| Fiscal year | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 7 | 3 | 234 | 329 | 616 | 800 |
| Growth on the year before | — | 0.0% | 0.0% | 0.0% | 0.0% | +>999% | −58.4% | +>999% | +40.8% | +87.3% | — |
| Gross profit | — | — | — | — | — | 6 | 3 | 220 | 291 | 516 | 659 |
| Gross margin | — | — | — | — | — | 88.2% | 90.5% | 94.0% | 88.3% | 83.7% | 82.4% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Products | $607M | 98.5% | ▲ 93.5% |
| Licenses | $9.4M | 1.5% | ▼ 38.7% |
| Royalty (part of Licenses) | $5.6M | 60.0% | ▲ 601.0% |
| Other Revenue (part of Licenses) | $3.6M | 38.4% | ▲ 97.0% |
| License Revenue (part of Licenses) | $152,000 | 1.6% | 0.0% |
| Milestone | $0 | 0.0% | ▼ 100.0% |
From TG Therapeutics, Inc.'s 10-K filed February 27, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| TG Therapeutics, Inc. | $800m | 76.1% | 221.5% |
| Telix Pharmaceuticals Ltd | $804m | 55.6% | — |
| Ascendis Pharma A/s | $814m | 106.9% | — |
| Ionis Pharmaceuticals Inc | $874m | -7.4% | 11.5% |
| Ultragenyx Pharmaceutical Inc. | $717m | 17.5% | 21.2% |
| Nurix Therapeutics, Inc. | $702m | 738.8% | 117.1% |
Compare with peers
- Telix Pharmaceuticals Ltd revenue
- Ascendis Pharma A/s revenue
- Ionis Pharmaceuticals Inc revenue
- Ultragenyx Pharmaceutical Inc. revenue
- Nurix Therapeutics, Inc. revenue
Head to head: TGTX vs TLXASND vs TGTXIONS vs TGTXRARE vs TGTX
More: Biotechnology stocks compared, Health Care sector, rankings of US companies